Marathi
|
Hindi
Download App
Epaper
Home
City
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Chhatrapati Sambhajinagar
Nagpur
Entertainment
Photos
Business
Technology
Sports
Lifestyle
Social Viral
Lokmat Games
Health
City
Home
Latest News
Cricket
LT Premium
National
International
Maharashtra
Opinions
Nagpur
Chhatrapati Sambhajinagar
Trending Topics :
Lok Sabha Election 2024
Heatwave In India
Mumbai Water Cut
Maharashtra Lok Sabha Election
IPL 2024
Salman Khan
All
News
Photos
Videos
Gilead Sciences Inc
FOLLOW
Gilead sciences inc, Latest News
Gilead Sciences, Inc., is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs.
Read More
National :
Centre prohibits exports of Remdesivir till COVID-19 situation in India improves
The Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the Covid-19 situation in the country improves. ...
Business :
Dr Reddy's launches Redyx (Remdesivir) in India for COVID-19 treatment
Dr Reddy's Laboratories on Wednesday announced the launch of Remdesivir under the brand name Redyx for Indian markets. ...
National :
Fresh guidelines for Remdesivir injection for private hospitals treating govt patients in Karnataka
The Karnataka government has said that while Remdesivir injections have already been used in government hospitals, the same benefits will be extended to the patients referred through the government to private hospitals. ...
Business :
At Rs 2,800, Zydus launches Remdac for treatment of COVID-19 in India
Pharmaceutical major Zydus Cadila said on Thursday it has launched Remdesivir under the brand name Remdac for treatment of COVID-19 in the Indian market. ...
Business :
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial
Global pharmaceutical major Mylan has got approval for its remdesivir from the Drug Controller General of India (DCGI) and will launch a generic version of Gilead Sciences' COVID-19 anti-viral in the country at Rs 4,800 for 100 mg/vial. ...
Business :
Dr Reddy's Labs in licensing pact with Gilead Sciences for Remdesivir
Dr Reddy's Laboratories said on Saturday it has entered into a non-exclusive licensing agreement with Gilead Sciences Inc that will grant Dr Reddy's the right to register, manufacture and sell Gilead's investigational drug Remdesivir, a potential tre ...
National :
COVID-19: Remdesivir gets nod from CDCSO for 'restricted emergency use' on hospitalised patients
In a significant development, the country's top drug controller the Central Drug Control Standard Organisation (CDCSO) has given permission to Gilead Sciences for marketing authorization of its anti-viral drug Remdesivir "only for restricted emergenc ...
International :
How Singapore, India are contributing to a COVID-19 vaccine race
With the COVID-19 cases zipping past five million people globally last week and rocketing towards six million, the search for a vaccine and a therapy has become more and more urgent. ...
Previous Page
Next Page